论文部分内容阅读
目的探讨射频消融(RFA)规范化治疗对提高肝肿瘤疗效的价值。方法回顾性分析2010年7月至2012年7月收治的302例(476个肝脏恶性肿瘤)肝肿瘤患者的临床资料。结果与转移性肝癌(MLC)相比,原发性肝癌(HCC)患者的2年和3年生存率明显较高,两者差异有统计学意义(P<0.001);HCC患者中,与Ⅲ~Ⅳ期患者相比,Ⅰ~Ⅱ期患者的1、2和3年生存率均较高,两者差异有统计学意义(P<0.05)。结论射频消融规范化治疗对提高肝肿瘤疗效具有较高价值,值得临床推广。
Objective To investigate the value of radiofrequency ablation (RFA) standardization therapy in improving the efficacy of liver tumors. Methods The clinical data of 302 patients (476 liver malignancies) with liver cancer who were treated from July 2010 to July 2012 were retrospectively analyzed. Results Compared with MLC, the 2-year and 3-year survival rates of HCC patients were significantly higher than those of MLC patients (P <0.001). In HCC patients, Compared with patients with stage Ⅳ ~ Ⅳ, the 1-year, 2-year and 3-year survival rates were higher in patients with stage Ⅰ ~ Ⅱ, the difference was statistically significant (P <0.05). Conclusion The standardization of radiofrequency ablation has a high value for improving the curative effect of liver tumors and is worthy of clinical promotion.